Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, CT13 9NJ, UK
Provera 10 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablets. |
Each tablet contains 10 mg medroxyprogesterone acetate.
Excipients with known effect: Lactose monohydrate 110 mg, sucrose 2 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Medroxyprogesterone |
Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects. |
| List of Excipients |
|---|
|
Lactose |
HDPE tamper-evident bottles with LDPE push-fit tamper evident caps, containing 50 tablets.
Aluminium foil/PVC blisters, containing 10, 20, 30, 50, 90 or 100 tablets.
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich, CT13 9NJ, UK
PL 00057/1033
Date of first authorisation: 21 September 2010
| Drug | Countries | |
|---|---|---|
| PROVERA | Australia, Brazil, Canada, Ecuador, Estonia, Finland, Hong Kong, Croatia, Ireland, Israel, Japan, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
